Carregant...
Role of lapatinib alone or in combination in the treatment of HER2-positive breast cancer
PURPOSE: This review aims to present the preclinical and clinical data regarding efficacy and safety of lapatinib alone and in combination with other agents in the treatment of human epidermal growth factor receptor-2 (HER2)-overexpressing breast cancer. BACKGROUND: HER2-positive (HER2+) breast canc...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove Medical Press
2012
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3846547/ https://ncbi.nlm.nih.gov/pubmed/24367193 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BCTT.S29996 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|